These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

453 related items for PubMed ID: 9151296

  • 1. Involvement of mu- and delta-opioid receptors in the effects of systemic and locally perfused morphine on extracellular levels of dopamine, DOPAC and HVA in the nucleus accumbens of the halothane-anaesthetized rat.
    Borg PJ, Taylor DA.
    Naunyn Schmiedebergs Arch Pharmacol; 1997 May; 355(5):582-8. PubMed ID: 9151296
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Fentanyl increases dopamine release in rat nucleus accumbens: involvement of mesolimbic mu- and delta-2-opioid receptors.
    Yoshida Y, Koide S, Hirose N, Takada K, Tomiyama K, Koshikawa N, Cools AR.
    Neuroscience; 1999 May; 92(4):1357-65. PubMed ID: 10426490
    [Abstract] [Full Text] [Related]

  • 4. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
    Hirose N, Murakawa K, Takada K, Oi Y, Suzuki T, Nagase H, Cools AR, Koshikawa N.
    Neuroscience; 2005 May; 135(1):213-25. PubMed ID: 16111831
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Orphanin FQ reduces morphine-induced dopamine release in the nucleus accumbens: a microdialysis study in rats.
    Di Giannuario A, Pieretti S, Catalani A, Loizzo A.
    Neurosci Lett; 1999 Sep 17; 272(3):183-6. PubMed ID: 10505611
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Implication of Rho-associated kinase in the elevation of extracellular dopamine levels and its related behaviors induced by methamphetamine in rats.
    Narita M, Takagi M, Aoki K, Kuzumaki N, Suzuki T.
    J Neurochem; 2003 Jul 17; 86(2):273-82. PubMed ID: 12871568
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Differential effects of delta- and mu-opioid receptor antagonists on the amphetamine-induced increase in extracellular dopamine in striatum and nucleus accumbens.
    Schad CA, Justice JB, Holtzman SG.
    J Neurochem; 1996 Dec 17; 67(6):2292-9. PubMed ID: 8931460
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Handling and/or saline injections alter basal and morphine-evoked changes in dopamine metabolites in the striatum and nucleus accumbens of rats.
    Johnson DW, Glick SD.
    Pharmacol Biochem Behav; 1994 Mar 17; 47(3):765-8. PubMed ID: 8208798
    [Abstract] [Full Text] [Related]

  • 15. Altered nucleus accumbens circuitry mediates pain-induced antinociception in morphine-tolerant rats.
    Schmidt BL, Tambeli CH, Barletta J, Luo L, Green P, Levine JD, Gear RW.
    J Neurosci; 2002 Aug 01; 22(15):6773-80. PubMed ID: 12151557
    [Abstract] [Full Text] [Related]

  • 16. Shell/core differences in mu- and delta-opioid receptor modulation of dopamine efflux in nucleus accumbens.
    Hipólito L, Sánchez-Catalán MJ, Zanolini I, Polache A, Granero L.
    Neuropharmacology; 2008 Aug 01; 55(2):183-9. PubMed ID: 18582908
    [Abstract] [Full Text] [Related]

  • 17. Identification of the opioid receptor types mediating beta-endorphin-induced alterations in dopamine release in the nucleus accumbens.
    Spanagel R, Herz A, Shippenberg TS.
    Eur J Pharmacol; 1990 Nov 06; 190(1-2):177-84. PubMed ID: 1981749
    [Abstract] [Full Text] [Related]

  • 18. The 5-HT1A receptor antagonist (S)-UH-301 decreases dopamine release in the rat nucleus accumbens and striatum.
    Nomikos GG, Arborelius L, Höök BB, Hacksell U, Svensson TH.
    J Neural Transm (Vienna); 1996 Nov 06; 103(5):541-54. PubMed ID: 8811500
    [Abstract] [Full Text] [Related]

  • 19. Increased levels of extracellular dopamine in neostriatum and nucleus accumbens after histamine H1 receptor blockade.
    Dringenberg HC, de Souza-Silva MA, Schwarting RK, Huston JP.
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Oct 06; 358(4):423-9. PubMed ID: 9826064
    [Abstract] [Full Text] [Related]

  • 20. A protein kinase inhibitor, H-7, blocks naloxone-precipitated changes in dopamine and its metabolites in the brains of opioid-dependent rats.
    Tokuyama S, Ho IK, Yamamoto T.
    Brain Res Bull; 2000 Jul 15; 52(5):363-9. PubMed ID: 10922515
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.